Tennessee will receive more than $3 million in a settlement with pharmaceutical company Cephalon, now part of Teva Pharmaceutical Industries, Attorney General Herbert H. Slatery III announced today.
The settlement comes after litigation, led by the Federal Trade Commission, accused Cephalon and its competitors of anticompetitive conduct, keeping a generic version of the drug Provigil, a drug used to treat sleeping disorders, off the market for six years. Cephalon was accused of paying competitors…
Tennessee will receive more than $3 million in a settlement with pharmaceutical company Cephalon, now part of Teva Pharmaceutical Industries, Attorney General Herbert H. Slatery III announced today.
The settlement comes after litigation, led by the Federal Trade Commission, accused Cephalon and its competitors of anticompetitive conduct, keeping a generic version of the drug Provigil, a drug used to treat sleeping disorders, off the market for six years. Cephalon was accused of paying competitors…